Reasons for poor prognosis in British patients with cutaneous malignant melanoma
- PMID: 3083979
- PMCID: PMC1339918
- DOI: 10.1136/bmj.292.6526.987
Reasons for poor prognosis in British patients with cutaneous malignant melanoma
Abstract
One hundred and twenty five patients presenting in the west of Scotland with primary cutaneous malignant melanoma answered a detailed questionnaire to establish whether there was any evidence of inappropriate delay in receiving surgical treatment for a new or changing pigmented lesion. The survey was carried out because of the relatively high proportion of patients in Scotland with melanoma presenting with primary lesions categorised as "thick, poor prognosis" and the poor five year survival figures as compared with many other countries. Of the 125 patients questioned, only 20 (16%) had received appropriate surgical treatment within three months of becoming aware of a suspicious cutaneous pigmented lesion; 63 (50%) had received surgical treatment three to 12 months after first noticing such a change, and in 42 cases (34%) this interval was over one year. In 102 of 105 patients in whom the interval exceeded three months the patient alone was responsible for the delay; in only three cases was the family doctor partially at fault. No evidence of delay by the hospital service was identified. Because of these findings a public education campaign was launched in the west of Scotland in June 1985 with the aim of improving recognition of early malignant melanoma. In the next six months the proportion of patients in the west of Scotland with primary melanomas categorised as "thin, good prognosis" had risen from 38% to 62%, and the proportion with tumours categorised as "thick, poor prognosis" had fallen from 34% to 15%.
Similar articles
-
Experience of a public education programme on early detection of cutaneous malignant melanoma.BMJ. 1988 Aug 6;297(6645):388-91. doi: 10.1136/bmj.297.6645.388. BMJ. 1988. PMID: 3408978 Free PMC article.
-
Thick melanoma: the challenge persists.Br J Dermatol. 2005 Jan;152(1):104-9. doi: 10.1111/j.1365-2133.2005.06409.x. Br J Dermatol. 2005. PMID: 15656809
-
Incidence and thickness of primary tumours and survival of patients with cutaneous malignant melanoma in relation to socioeconomic status.BMJ. 1996 May 4;312(7039):1125-8. doi: 10.1136/bmj.312.7039.1125. BMJ. 1996. PMID: 8620127 Free PMC article.
-
Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.Acta Dermatovenerol Croat. 2018 Apr;26(1):64-67. Acta Dermatovenerol Croat. 2018. PMID: 29782304 Review.
-
Melanoma in the South-East of Scotland: a review.Scott Med J. 1980 Jul;25(3):222-6. doi: 10.1177/003693308002500307. Scott Med J. 1980. PMID: 7003707 Review.
Cited by
-
Incidence and mortality trends of melanoma in Croatia.Croat Med J. 2012 Apr;53(2):135-40. doi: 10.3325/cmj.2012.53.135. Croat Med J. 2012. PMID: 22522991 Free PMC article.
-
Experience of a public education programme on early detection of cutaneous malignant melanoma.BMJ. 1988 Aug 6;297(6645):388-91. doi: 10.1136/bmj.297.6645.388. BMJ. 1988. PMID: 3408978 Free PMC article.
-
Role of primary care in the prevention of malignant melanoma.Br J Gen Pract. 1994 Nov;44(388):523-6. Br J Gen Pract. 1994. PMID: 7748650 Free PMC article. Review.
-
Cutaneous Malignant Melanoma: A Review of Early Diagnosis and Management.World J Oncol. 2021 Feb;12(1):7-19. doi: 10.14740/wjon1349. Epub 2021 Feb 24. World J Oncol. 2021. PMID: 33738001 Free PMC article. Review.
-
Defining an acceptable period of time from melanoma biopsy to excision.Dermatol Reports. 2012 Jan 17;4(1):e2. doi: 10.4081/dr.2012.e2. eCollection 2012 Jan 2. Dermatol Reports. 2012. PMID: 25386312 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical